For full functionality, including active links, we recommend downloading the PDF. Certain interactive features may not operate within the embedded viewer.
Download this PDF file

 

Crossref Citations

1. Real‐world use and outcomes of dolutegravir‐containing antiretroviral therapy in HIV and tuberculosis co‐infection: a site survey and cohort study in sub‐Saharan Africa
Matthew L. Romo, Ellen Brazier, Dominique Mahambou‐Nsondé, Reneé De Waal, Christine Sekaggya‐Wiltshire, Cleophas Chimbetete, Winnie R. Muyindike, Gad Murenzi, Cordelia Kunzekwenyika, Thierry Tiendrebeogo, Josephine A. Muhairwe, Patricia Lelo, Anastase Dzudie, Christelle Twizere, Idiovino Rafael, Oliver C. Ezechi, Lameck Diero, Marcel Yotebieng, Lukas Fenner, Kara K. Wools‐Kaloustian, N. Sarita Shah, Denis Nash
Journal of the International AIDS Society  vol: 25  issue: 7  year: 2022  
doi: 10.1002/jia2.25961

2. Virological Findings and Treatment Outcomes of Cases That Developed Dolutegravir Resistance in Malawi’s National HIV Treatment Program
Hope Kanise, Joep J. van Oosterhout, Pachawo Bisani, John Songo, Bilaal W. Matola, Chifundo Chipungu, Katherine Simon, Carrie Cox, Mina C. Hosseinipour, Jean-Batiste Sagno, Risa M. Hoffman, Claudia Wallrauch, Sam Phiri, Kim Steegen, Andreas Jahn, Rose Nyirenda, Tom Heller
Viruses  vol: 16  issue: 1  first page: 29  year: 2023  
doi: 10.3390/v16010029

3. Development and Optimization of Oligonucleotide Ligation Assay (OLA) Probes for Detection of HIV-1 Resistance to Dolutegravir
Ingrid A. Beck, Ceejay L. Boyce, Marley D. Bishop, Yen L. Vu, Amanda Fung, Sheila Styrchak, Nuttada Panpradist, Barry R. Lutz, Lisa M. Frenkel
Viruses  vol: 16  issue: 7  first page: 1162  year: 2024  
doi: 10.3390/v16071162

4. HIV Dolutegravir resistance and multiclass failure in Mozambique: findings from a real-world cohort
Fausto Ciccacci, Anna Maria Doro Altan, Noorjehan Majid, Stefano Orlando, Elton Uamusse, Marcia Rafael, Zita Sidumo, Paola Germano, Giovanni Guidotti, Carlo Federico Perno
BMC Infectious Diseases  vol: 25  issue: 1  year: 2025  
doi: 10.1186/s12879-025-11639-2

5. Primary resistance against integrase strand transfer inhibitors in integrase strand transfer inhibitor-naive patients failing first- and second-line ART in Tanzania
Shimba Henerico, Eric Lyimo, Abel N Makubi, Daniel Magesa, Bernard Desderius, Andreas Mueller, John Changalucha, Samuel E Kalluvya, Gert Van Zyl, Wolfgang Preiser, Stephen E Mshana, Christa Kasang
Journal of Antimicrobial Chemotherapy  vol: 77  issue: 11  first page: 3138  year: 2022  
doi: 10.1093/jac/dkac295

6. HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis
Ezechiel Ngoufack Jagni Semengue, Maria Mercedes Santoro, Valantine Ngum Ndze, Aude Christelle Ka’e, Bouba Yagai, Alex Durand Nka, Beatrice Dambaya, Desiré Takou, Georges Teto, Lavinia Fabeni, Vittorio Colizzi, Carlo-Federico Perno, Francesca Ceccherini-Silberstein, Joseph Fokam, Kévin Jean
PLOS Global Public Health  vol: 2  issue: 10  first page: e0000826  year: 2022  
doi: 10.1371/journal.pgph.0000826

7. Dolutegravir Resistance in African Programmatic Settings Among Patients With Failure of Dolutegravir-based ART
Richard A Murphy, Pradeep H Bedesi, Nirmala Perumal, Bernadett I Gosnell, Timothy J Hatlen, Jaysingh Brijkumar
Open Forum Infectious Diseases  vol: 11  issue: 7  year: 2024  
doi: 10.1093/ofid/ofae321

8. Research Progress on Influencing Factors of AIDS Curative Effect
金玲 刘
Advances in Clinical Medicine  vol: 13  issue: 07  first page: 11153  year: 2023  
doi: 10.12677/ACM.2023.1371557

9. Treatment Emergent Dolutegravir Resistance Mutations in Individuals Naïve to HIV-1 Integrase Inhibitors: A Rapid Scoping Review
Kaiming Tao, Soo-Yon Rhee, Carolyn Chu, Ava Avalos, Amrit K. Ahluwalia, Ravindra K. Gupta, Michael R. Jordan, Robert W. Shafer
Viruses  vol: 15  issue: 9  first page: 1932  year: 2023  
doi: 10.3390/v15091932

10. Dolutegravir resistance in sub-Saharan Africa: should resource-limited settings be concerned for future treatment?
Doreen Kamori, Godfrey Barabona
Frontiers in Virology  vol: 3  year: 2023  
doi: 10.3389/fviro.2023.1253661

11. Pan-Resistant HIV-1 Drug Resistance Among Highly Treated Patients with Virological Failure on Dolutegravir-Based Antiretroviral Therapy in Zimbabwe
Tendai Washaya, Benjamin Chimukangara, Justin Mayini, Sandra Bote, Nyasha Chin’ombe, Shungu Munyati, Justen Manasa
Viruses  vol: 17  issue: 10  first page: 1348  year: 2025  
doi: 10.3390/v17101348